Tiziana Life Sciences Ltd. (Bermuda) (TLSA)
0.9501
-0.05
(-4.99%)
USD |
NASDAQ |
Oct 23, 16:00
0.95
0.00 (0.00%)
After-Hours: 20:00
Tiziana Life Sciences Market Cap : 121.64M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 121.64M |
| October 22, 2026 | 128.03M |
| October 21, 2026 | 129.31M |
| October 20, 2026 | 129.31M |
| October 19, 2026 | 129.31M |
| October 16, 2026 | 134.43M |
| October 15, 2026 | 134.43M |
| October 14, 2026 | 134.43M |
| October 13, 2026 | 139.55M |
| October 12, 2026 | 131.35M |
| October 09, 2026 | 143.40M |
| October 08, 2026 | 136.17M |
| October 07, 2026 | 132.56M |
| October 06, 2026 | 133.76M |
| October 05, 2026 | 128.94M |
| October 02, 2026 | 134.97M |
| October 01, 2026 | 137.38M |
| September 30, 2026 | 133.76M |
| September 29, 2026 | 114.93M |
| September 28, 2026 | 118.16M |
| September 25, 2026 | 121.71M |
| September 24, 2026 | 125.33M |
| September 23, 2026 | 126.53M |
| September 22, 2026 | 107.24M |
| September 21, 2026 | 109.01M |
| Date | Value |
|---|---|
| September 18, 2026 | 109.13M |
| September 17, 2026 | 116.89M |
| September 16, 2026 | 92.80M |
| September 15, 2026 | 102.67M |
| September 14, 2026 | 107.28M |
| September 11, 2026 | 115.69M |
| September 10, 2026 | 116.17M |
| September 09, 2026 | 117.70M |
| September 08, 2026 | 119.27M |
| September 04, 2026 | 122.92M |
| September 03, 2026 | 117.43M |
| September 02, 2026 | 112.25M |
| September 01, 2026 | 116.12M |
| August 31, 2026 | 119.06M |
| August 28, 2026 | 121.71M |
| August 27, 2026 | 130.15M |
| August 26, 2026 | 131.35M |
| August 25, 2026 | 133.76M |
| August 24, 2026 | 138.58M |
| August 21, 2026 | 137.38M |
| August 20, 2026 | 134.97M |
| August 19, 2026 | 128.94M |
| August 18, 2026 | 134.97M |
| August 17, 2026 | 138.58M |
| August 14, 2026 | 136.78M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.396B |
| Alkermes Plc | 7.310B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Amarin Corp. Plc | 247.62M |
| Anika Therapeutics, Inc. | 286.66M |
Market Cap Related Metrics
| PEG Ratio | -0.0874 |
| Price | 0.9501 |
| Earnings Yield | -21.52% |
| PEGY Ratio | -0.0874 |